NCT02882100 - Adjuvanted Influenza Vaccination in U.S. Nursing Homes | Biotech Hunter

Enrollment

823

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

October 4, 2018

Study Completion Date

January 25, 2023

Conditions

InfluenzaInfluenza-like Illness

Interventions

BIOLOGICAL

adjuvanted trivalent influenza vaccine

Nursing home residents over 65 years are allocated to receive adjuvanted trivalent vaccine. Residents under 65 years are provided standard trivalent vaccine (TIV-Fluvirin).

BIOLOGICAL

trivalent influenza vaccine

Nursing home residents are allocated to receive standard trivalent vaccine (TIV).

Trial Locations (1)

23510

Insight Therapeutics, LLC, Norfolk